216 related articles for article (PubMed ID: 17952581)
1. Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine.
Yilmaz MB; Yalta K; Yontar C; Karadas F; Erdem A; Turgut OO; Yilmaz A; Tandogan I
Cardiovasc Drugs Ther; 2007 Dec; 21(6):431-5. PubMed ID: 17952581
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application. Editorial to: "Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine by Yilmaz et al.".
Damman K; Voors AA
Cardiovasc Drugs Ther; 2007 Dec; 21(6):403-4. PubMed ID: 18030611
[No Abstract] [Full Text] [Related]
3. Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.
Hou ZQ; Sun ZX; Su CY; Tan H; Zhong X; Hu B; Zhou Y; Shang DY
Cardiovasc Ther; 2013 Apr; 31(2):108-14. PubMed ID: 23490237
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
[TBL] [Abstract][Full Text] [Related]
5. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
Duygu H; Ozerkan F; Zoghi M; Nalbantgil S; Yildiz A; Akilli A; Akin M; Nazli C; Ergene O
Int J Clin Pract; 2008 Feb; 62(2):228-33. PubMed ID: 17949428
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure.
Paraskevaidis IA; Bistola V; Ikonomidis I; Parissis JT; Papadopoulos C; Filippatos G; Kremastinos DT
Am J Cardiol; 2008 Nov; 102(9):1225-9. PubMed ID: 18940297
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure.
Yontar OC; Yilmaz MB; Yalta K; Erdem A; Tandogan I
Arq Bras Cardiol; 2010 Dec; 95(6):738-42. PubMed ID: 21109913
[TBL] [Abstract][Full Text] [Related]
8. [Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].
Tek M; Cavuşoğlu Y; Demirüstü C; Birdane A; Ünalır A; Görenek B; Göktekin Ö; Ata N
Turk Kardiyol Dern Ars; 2010 Jul; 38(5):334-40. PubMed ID: 21200103
[TBL] [Abstract][Full Text] [Related]
9. The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine.
Avgeropoulou C; Andreadou I; Markantonis-Kyroudis S; Demopoulou M; Missovoulos P; Androulakis A; Kallikazaros I
Eur J Heart Fail; 2005 Aug; 7(5):882-7. PubMed ID: 15921958
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan: a review of its use in the management of acute decompensated heart failure.
Innes CA; Wagstaff AJ
Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085
[TBL] [Abstract][Full Text] [Related]
11. Effects of levosimendan on left atrial functions in patients with ischemic heart failure.
Duygu H; Nalbantgil S; Ozerkan F; Zoghi M; Akilli A; Erturk U; Akin M; Nazli C; Ergene O
Clin Cardiol; 2008 Dec; 31(12):607-13. PubMed ID: 19072879
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
Mebazaa A; Nieminen MS; Packer M; Cohen-Solal A; Kleber FX; Pocock SJ; Thakkar R; Padley RJ; Põder P; Kivikko M;
JAMA; 2007 May; 297(17):1883-91. PubMed ID: 17473298
[TBL] [Abstract][Full Text] [Related]
13. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
Cavusoglu Y
Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
[TBL] [Abstract][Full Text] [Related]
14. Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording.
Despas F; Trouillet C; Franchitto N; Labrunee M; Galinier M; Senard JM; Pathak A
Acute Card Care; 2010 Mar; 12(1):25-30. PubMed ID: 19929264
[TBL] [Abstract][Full Text] [Related]
15. Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study.
Bragadottir G; Redfors B; Ricksten SE
Crit Care Med; 2013 Oct; 41(10):2328-35. PubMed ID: 23921271
[TBL] [Abstract][Full Text] [Related]
16. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure.
Yilmaz MB; Yontar C; Erdem A; Karadas F; Yalta K; Turgut OO; Yilmaz A; Tandogan I
Heart Vessels; 2009 Jan; 24(1):16-21. PubMed ID: 19165563
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms.
Fedele F; Bruno N; Brasolin B; Caira C; D'Ambrosi A; Mancone M
Eur J Heart Fail; 2014 Mar; 16(3):281-8. PubMed ID: 24464960
[TBL] [Abstract][Full Text] [Related]
19. A comparison of hemodynamic effects of levosimendan and dobutamine in patients undergoing mitral valve repair / replacement for severe mitral stenosis.
Gandham R; Syamasundar A; Ravulapalli H; Karthekeyan RB; Vakamudi M; Kodalli R; Nandipati S
Ann Card Anaesth; 2013; 16(1):11-5. PubMed ID: 23287080
[TBL] [Abstract][Full Text] [Related]
20. Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
Duygu H; Ozerkan F; Nalbantgil S; Zoghi M; Akilli A; Akin M; Nazli C; Ergene O
Int J Cardiol; 2008 Jan; 123(2):201-3. PubMed ID: 17316845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
